FDA approves a game-changing treatment for blood cancer
The Food and Drug Administration has approved a promising new treatment called CAR-T for a particularly deadly form of cancer.
The Food and Drug Administration on Wednesday approved a promising new treatment for a particularly deadly form of cancer, bringing hope to desperate patients while rekindling a global conversation about the escalating cost of new therapies.
The treatment, made by Gilead Sciences, is made by extracting patients’ white blood cells and re-engineering them to
